Clinical Trial: A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Rheumatoid Arthritis
Study Type: INTERVENTIONAL
Official Title: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis
Brief Summary:
The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoid arthritis.
Read more